PIPatrizia Di Iorio

Patrizia Di Iorio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Patrizia Di Iorio has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Patricia Giuliani

    Department of Medical, Oral and Biotechnological Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy

    4 shared publications
  • Renata Ciccarelli

    Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Via dei Vestini 29, 66100 Chieti, Italy

    3 shared publications
  • Francesco Caciagli

    Department of Medical and Oral Sciences and Biotechnologies, “G.d’Annunzio” University of Chieti-Pescara, Chieti, Italy

    2 shared publications
  • Giuseppa Mudò

    Department of Biomedicine, Neuroscience and advanced Diagnostic, University of Palermo, Palermo, Italy

    2 shared publications
  • Michel Rathbone

    Department of Medicine, Division of Neurology, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada

    2 shared publications
  • Patrizia Ballerini

    Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy; Department of Innovative Technologies in Medicine and Dentistry, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy

    2 shared publications

Latest Publications

  • Open Access

    Guanosine modulates K+ membrane currents in SH-SY5Y cells: involvement of adenosine receptors

    by Giuditta Gambino, Giuseppe Giglia, Daniele Gallo, Miriana Scordino, Costanza Giardina, Mariachiara Zuccarini, Patrizia Di Iorio, Patricia Giuliani, Francisco Ciruela, Giuseppe Ferraro, et al.

    Guanosine (GUO), widely considered a key signaling mediator, is implicated in the regulation of several cellular processes. While its interaction with neural membranes has been described, GUO still is an orphan neuromodulator. It has been postulated that GUO may eventually interact with potassium channels and adenosine (ADO) receptors (ARs), both particularly important for the control of cellular excitability. Accordingly, here, we investigated the effects of GUO on the bioelectric activity of human neuroblastoma SH-SY5Y cells by whole-cell patch-clamp recordings. We first explored the contribution of voltage-dependent K+ channels and, besides this, the role of ARs in the regulation of GUO-dependent cellular electrophysiology. Our data support that GUO is able to specifically modulate K+-dependent outward currents over cell membranes. Importantly, administering ADO along with GUO potentiates its effects. Overall, these results suggested that K+ outward membrane channels may be targeted by GUO with an implication of ADO receptors in SH-SY5Y cells, but also support the hypothesis of a functional interaction of the two ligands. The present research runs through the leitmotif of the deorphanization of GUO, adding insight on the interplay with adenosinergic signaling and suggesting GUO as a powerful modulator of SH-SY5Y excitability.


  • Retracted
    Open Access

    RETRACTED ARTICLE: Modulation of the TGF-β1-induced epithelial to mesenchymal transition (EMT) mediated by P1 and P2 purine receptors in MDCK cells

    by Mariachiara Zuccarini, Patricia Giuliani, Silvana Buccella, Valentina Di Liberto, Giuseppa Mudò, Natale Belluardo, Marzia Carluccio, Margherita Rossini, Daniele Filippo Condorelli, Michel Piers Rathbone, et al.

    Epithelial to mesenchymal transition (EMT) occurs during embryogenesis or under pathological conditions such as hypoxia, injury, chronic inflammation, or tissue fibrosis. In renal tubular epithelial cells (MDCK), TGF-β1 induces EMT by reducing or increasing epithelial or mesenchymal marker expression, respectively. In this study, we confirmed that the cAMP analogues, 8-CPT-cAMP or N6-Ph-cAMP, inhibited the TGF-β1-driven overexpression of the mesenchymal markers ZEB-1, Slug, Fibronectin, and α-SMA. Furthermore, we showed that A1, A2A, P2Y1, P2Y11, and P2X7 purine receptor agonists modulated the TGF-β1-induced EMT through the involvement of PKA and/or MAPK/ERK signaling. The stimulation of A2A receptor reduced the overexpression of the EMT-related markers, mainly through the cAMP-dependent PKA pathway, as confirmed by cell pre-treatment with Myr-PKI. Both A1 and P2Y1 receptor stimulation exacerbated the TGF-β1-driven effects, which were reduced by cell pre-treatment with the MAPK inhibitor PD98059, according to the increased ERK1/2 phosphorylation upon receptor activation. The effects induced by P2Y11 receptor activation were oppositely modulated by PKA or MAPK inhibition, in line with the dual nature of the Gs- and Gq-coupled receptor. Differently, P2X7 receptor induced, per se, similar and not additive effects compared to TGF-β1, after prolonged cell exposure to BzATP. These results suggest a putative role of purine receptors as target for anti-fibrotic agents.


  • Purine nucleosides protect injured neurons and stimulate neuronal regeneration by intracellular and membrane receptor‐mediated mechanisms

    by Patrizia Di Iorio, Francesco Caciagli, Patricia Giuliani, Patrizia Ballerini, Renata Ciccarelli, Oded Sperling, Esther Zoref‐Shani, Larry Benowitz, Ugo Traversa, Giulia Bombi, et al.

    Like adenine‐based purines, extracellular nonadenine‐based purines have a multitude of trophic effects on the growth, differentiation, and survival of target cells. The nonadenine‐based purines, which include guanosine, inosine, and GTP, apparently exert their trophic effects by interacting with both intercellular targets as well as those on the cell surface. Specifically, guanosine and inosine target the protein kinase N‐kinase, in promoting remarkable nerve process extension, even in long tracts of the central nervous system after injury. In contrast, GTP may exert its effects via a cell surface receptor coupled to the release of calcium from internal stores. In other cases trophic effects may be mediated by the enhancement of release of adenine‐based purines by guanosine. Additionally, evidence is presented for the existence of a high‐affinity binding site for guanosine with receptor‐like characteristics on the plasma membranes of astrocytes and brain tissue. This site may be G‐protein‐coupled and exert its effects through activation of the MAP kinase cascade. One effect apparently mediated through this mechanism is the production and release by astrocytes of trophic protein growth factors such as NGF and TGFβ. These have substantial neuroprotective effects. Additionally, this pathway is apparently involved in modulating the expression of P2Y1 and P2Y2 receptors in response to extracellular guanosine. Extracellular nonadenine‐based purines can interact with other growth factors, but these interactions are not always synergistic. For example, combinations of guanosine and FGF are antagonistic and reduce the growth of microvascular cells in vitro. Some of the properties of the nonadenine‐based purines likely derive from their unique intracellular metabolism in which conversion of guanine to xanthine is the final catabolic step. This step is catalyzed by guanase, the activity of which varies markedly in different brain regions, raising the possibility that guanine or guanosine are involved in neurotransmission. Together these data suggest several potentially useful pharmacological approaches involving nonadenine‐based purines to modulate trophic effects in the central nervous system. Drug Dev. Res. 52:303–315, 2001.


  • Class II of metabotropic glutamate receptors modulate the evoked release of adenosine and glutamate from rat hippocampal slices

    by F. Caciagli, P. Di Iorio, R. Ciccarelli, P. Ballerini, P. Giuliani, H. Shinozaki, F. Nicoletti